Immune Pharmaceuticals, Inc.

OTCPK:IMNP.Q Stock Report

Market Cap: US$402.0k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Immune Pharmaceuticals Management

Management criteria checks 2/4

Key information

Gary Rabin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure4.2yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Gary Rabin (54 yo)

1.3yrs

Tenure

Mr. Gary H. Rabin is Chief Executive Officer, President and Director of Immune Pharmaceuticals, Inc. since March 2019. He was Interim Chief Executive Officer of Immune Pharmaceuticals, Inc. in 2019. He has...


Leadership Team

NamePositionTenureCompensationOwnership
John Clark
Controller & Principal Accounting Officer1.4yrsUS$176.08kno data
Gary Rabin
Interim CEO & Director1.3yrsno datano data
Christine Petraglia
Director of Investor Relationsno datano datano data
Anna Baran-Djokovic
Director of Corporate Affairsno datano datano data
Miri Ben-Ami
President of Immune Oncology Pharmaceuticals Incno datano datano data
Boris Shor
Executive Director of R&D & Scientific Partnerships4.6yrsno datano data
Ranch Kimball
Strategic Advisorno datano datano data

2.3yrs

Average Tenure

Experienced Management: IMNP.Q's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gary Rabin
Interim CEO & Director1.3yrsno datano data
William Sandborn
Member of Scientific Advisory Boardno datano datano data
Brian Feagan
Member of Scientific Advisory Boardno datano datano data
Neil Korman
Member of Scientific Advisory Boardno datano datano data
Jean-Frédéric Colombel
Member of Scientific Advisory Boardno datano datano data
John Neczesny
Independent Director4.2yrsUS$60.00k0%
$ 0
Jeffrey Paley
Independent Director4.2yrsUS$60.00k0.00022%
$ 0.9
Daniel Kazado
Director6.5yrsUS$40.00k0.031%
$ 126.5
Pascal Joly
Member of Scientific Advisory Boardno datano datano data
Vicky Werth
Member of Scientific Advisory Boardno datano datano data

4.2yrs

Average Tenure

54yo

Average Age

Experienced Board: IMNP.Q's board of directors are considered experienced (4.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.